72 filings
PRE 14A
GLTO
Galecto Inc
16 Apr 24
Preliminary proxy
4:00pm
8-K
GLTO
Galecto Inc
26 Mar 24
Other Events
4:00pm
S-8
GLTO
Galecto Inc
8 Mar 24
Registration of securities for employees
4:29pm
10-K
2023 FY
GLTO
Galecto Inc
Annual report
8 Mar 24
4:00pm
8-K
GLTO
Galecto Inc
21 Dec 23
Other Events
4:30pm
8-K
d0fjgvl1gy k7q4h9w
23 Oct 23
Galecto Presents Updated Clinical Data at ESMO Congress 2023 and Provides Update on Phase 1b/2a GALLANT-1 Trial
9:00am
8-K
ijr7 fzj5eu26s1ds1
2 Oct 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:00pm
8-K
4brus31y6pyi7uzotibq
26 Sep 23
Galecto Announces Plans to Explore Strategic Alternatives
4:05pm
8-K
xtluuq
15 Aug 23
Galecto Announces Topline Results from Phase 2b GALACTIC-1 Trial of GB0139 for the Treatment of Idiopathic Pulmonary Fibrosis
8:00am
8-K
jlzchgj
15 Jun 23
Submission of Matters to a Vote of Security Holders
4:00pm
ARS
x79u4ljvl8ybqv
28 Apr 23
Annual report to shareholders
9:01am
DEFA14A
sgw x7s3rlkcfg
28 Apr 23
Additional proxy soliciting materials
7:45am
8-K
gn7xkp2g1uockdfb9 us
10 Mar 23
Regulation FD Disclosure
3:07pm
S-8
r75 a2r6qz715
9 Mar 23
Registration of securities for employees
6:36am
424B5
d0ajb kqr0k5re
9 Mar 23
Prospectus supplement for primary offering
6:31am